Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Secotex®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Study to evaluate the safety profile of Secotex® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice

Inclusion Criteria:

• Patients of any age with a diagnosis of symptomatic Benign Prostatic Hyperplasia (BPH)
• Patients with symptoms, that according to physician require medical treatment to improve quality of life
• Patients could be naive to treatment or could be on treatment with other drugs but have not responded adequately to treatment

Exclusion Criteria:

• Patients with known hypersensitivity to Tamsulosin, or any other component of the product
• Patients with a history of orthostatic hypotension or severe liver failure